Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
921 hedge funds and large institutions have $48.3B invested in Allergan plc in 2019 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 303 increasing their positions, 386 reducing their positions, and 129 closing their positions.
71% more funds holding in top 10
Funds holding in top 10: 58 → 99 (+41)
6% more capital invested
Capital invested by funds: $45.4B → $48.3B (+$2.89B)
5% less funds holding
Funds holding: 970 → 921 (-49)
22% less repeat investments, than reductions
Existing positions increased: 303 | Existing positions reduced: 386
35% less first-time investments, than exits
New positions opened: 84 | Existing positions closed: 129
53% less call options, than puts
Call options by funds: $895M | Put options by funds: $1.89B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.02B |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$977M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$853M |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
+$609M |
| 5 |
Citigroup
New York
|
+$603M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.43B |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$798M |
| 3 |
BG
Baupost Group
Boston,
Massachusetts
|
-$616M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$606M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$582M |
AGN Hedge Fund Activity: Q3 2019 in Review
921 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2019, worth a combined $48.3B — up 6.4% from $45.4B a quarter earlier.
Sellers outnumbered buyers: 129 funds closed out of AGN and 84 opened new positions — a net loss of 45 holders — while 386 trimmed existing stakes and 303 added.
The largest buyer was Credit Suisse, adding an estimated $1.02B. The largest seller was Wellington Management Group, cutting an estimated $3.43B.
- 921 institutional investors held Allergan plc (AGN) as of Q3 2019, down from 970 in Q2 2019.
- Funds reported $48.3B of Allergan plc stock for Q3 2019, up 6.4% quarter-over-quarter.
- 84 funds opened new Allergan plc positions in Q3 2019 and 129 closed out, a net change of -45 holders.
- The largest Allergan plc buyer in Q3 2019 was Credit Suisse, an estimated $1.02B added.
- The largest Allergan plc seller in Q3 2019 was Wellington Management Group, an estimated $3.43B sold.
Based on aggregated 13F filings for Q3 2019.